Printer Friendly

Newly approved generics make meds more affordable.

The U.S. Food & Drug Administration (FDA) announced in late June that it had approved the first generic version of the cholesterol-lowering medication simvastatin (Zocor). The generic version of simvastatin is expected to cost about half of the $4.40 per pill price of its name-brand counterpart. Simvastatin was the fourth generic drug to be approved within the same week. The FDA also gave the green light to generic versions of finasteride 1 mg tablets (Propecia) for hair loss, finasteride 5 mg tablets (Proscar) for benign prostatic hyperplasia (BPH) in men, and lamotrigine tablets (Lamictal) for epileptic seizures. The FDA estimates that increased competition from these generic drugs will save American consumers about $1 billion per year.

COPYRIGHT 2006 Belvoir Media Group, LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Focus on Healthy Aging
Article Type:Brief article
Geographic Code:1USA
Date:Sep 1, 2006
Previous Article:New screening tests: life-savers or money-wasters? A recent study finds Americans waste millions each year on unnecessary screening tests. Which...
Next Article:Meditate your way to a healthier heart.

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |